CATANZARO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 3.067
AS - Asia 1.392
EU - Europa 1.238
SA - Sud America 338
AF - Africa 303
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 20
Totale 6.390
Nazione #
US - Stati Uniti d'America 2.873
SG - Singapore 545
IT - Italia 385
CN - Cina 306
BR - Brasile 235
HK - Hong Kong 187
DE - Germania 98
PL - Polonia 96
SE - Svezia 92
FI - Finlandia 75
GB - Regno Unito 48
UA - Ucraina 44
NL - Olanda 42
VN - Vietnam 39
FR - Francia 37
IN - India 32
RU - Federazione Russa 32
CA - Canada 27
RO - Romania 25
MX - Messico 24
AT - Austria 21
TR - Turchia 20
EC - Ecuador 19
AR - Argentina 16
CZ - Repubblica Ceca 16
ES - Italia 16
KR - Corea 16
BE - Belgio 15
CO - Colombia 15
IE - Irlanda 15
SI - Slovenia 14
BZ - Belize 13
CH - Svizzera 13
YT - Mayotte 13
AE - Emirati Arabi Uniti 12
AO - Angola 12
AZ - Azerbaigian 12
BB - Barbados 12
DZ - Algeria 12
EE - Estonia 12
MK - Macedonia 12
TH - Thailandia 12
TZ - Tanzania 12
UZ - Uzbekistan 12
VE - Venezuela 12
BF - Burkina Faso 11
CR - Costa Rica 11
ID - Indonesia 11
MA - Marocco 11
PH - Filippine 11
PT - Portogallo 11
SA - Arabia Saudita 11
XK - ???statistics.table.value.countryCode.XK??? 11
DO - Repubblica Dominicana 10
ET - Etiopia 10
GM - Gambi 10
IQ - Iraq 10
JM - Giamaica 10
JO - Giordania 10
TT - Trinidad e Tobago 10
UG - Uganda 10
ZA - Sudafrica 10
AL - Albania 9
AU - Australia 9
BA - Bosnia-Erzegovina 9
BJ - Benin 9
CM - Camerun 9
CU - Cuba 9
GE - Georgia 9
HR - Croazia 9
IS - Islanda 9
JP - Giappone 9
KE - Kenya 9
KH - Cambogia 9
LU - Lussemburgo 9
RE - Reunion 9
RS - Serbia 9
SO - Somalia 9
ZW - Zimbabwe 9
CI - Costa d'Avorio 8
CL - Cile 8
CW - ???statistics.table.value.countryCode.CW??? 8
EG - Egitto 8
GH - Ghana 8
HN - Honduras 8
HU - Ungheria 8
LA - Repubblica Popolare Democratica del Laos 8
LY - Libia 8
MU - Mauritius 8
MY - Malesia 8
MZ - Mozambico 8
NZ - Nuova Zelanda 8
PE - Perù 8
TW - Taiwan 8
AD - Andorra 7
AM - Armenia 7
BO - Bolivia 7
CY - Cipro 7
GF - Guiana Francese 7
GT - Guatemala 7
Totale 6.089
Città #
Ashburn 369
Singapore 296
Fairfield 295
Chandler 217
Hong Kong 177
Ann Arbor 159
Woodbridge 153
Cambridge 135
Padova 133
Houston 131
Beijing 130
Wilmington 102
Boardman 94
Santa Clara 92
Seattle 88
Bytom 69
Princeton 60
Medford 58
Des Moines 51
Los Angeles 43
Helsinki 39
Munich 36
Malo 31
Nanjing 30
New York 28
Roxbury 27
San Diego 21
São Paulo 21
Warsaw 20
Ho Chi Minh City 18
Dallas 17
New Kensington 16
Milan 15
Washington 15
Buffalo 14
Brooklyn 13
Dublin 13
Baku 12
Chennai 12
Redondo Beach 12
Bridgetown 11
Chicago 11
Shenyang 11
Turku 11
Amman 10
Belo Horizonte 10
Catanzaro 10
Kampala 10
Mamoudzou 10
Nanchang 10
Phoenix 10
Rio de Janeiro 10
Tashkent 10
Vienna 10
Brussels 9
Dar es Salaam 9
Guangzhou 9
Harare 9
Havana 9
Hefei 9
Mexico City 9
Montreal 9
Phnom Penh 9
Tallinn 9
Tokyo 9
Abidjan 8
Accra 8
Amsterdam 8
Atlanta 8
Hebei 8
Pristina 8
Vientiane 8
Andorra la Vella 7
Castries 7
Istanbul 7
Jinan 7
Luanda 7
Lusaka 7
Nairobi 7
Niamey 7
Poplar 7
Porto Alegre 7
Rome 7
San José 7
Tripoli 7
Addis Ababa 6
Antananarivo 6
Belgrade 6
Boston 6
Cagliari 6
Chisinau 6
Cotonou 6
Dushanbe 6
Jacksonville 6
Lima 6
Ljubljana 6
Maputo 6
Nassau 6
Ouagadougou 6
Quito 6
Totale 3.742
Nome #
Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage 266
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells 224
Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death 204
A fixed combination of probiotics and herbal extracts attenuates intestinal barrier dysfunction from inflammatory stress in an in vitro model using Caco-2 cells. 183
Effect of Quercetin on Cell Cycle and Cyclin Expression in Ovarian Carcinoma and Osteosarcoma Cell Lines 181
Further assessment of Salvia haenkei as an innovative strategy to counteract skin photo-aging and restore the barrier integrity 175
Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T>C mitochondrial tRNAIle mutation causing hypertrophic cardiomyopathy. 171
Cell cycle control by natural phenols in cisplatin-resistant cell lines. 157
Protective effects of ψ taraxasterol 3-O-myristate and arnidiol 3-O-myristate isolated from Calendula officinalis on epithelial intestinal barrier 157
Chlorogenic Acid Interaction with Cisplatin and Oxaliplatin: Studies in Cervical Carcinoma Cells 157
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy 152
Attività antinfiammatoria e antiossidante di Boswellia serrata in un modello di epitelio intestinale in vitro. 149
Anti-inflammatory activity of Serenoa Repens on human prostate adenocarcinoma cells 148
Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2 146
Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression 145
Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress 143
Anti-ageing activity of Salvia haenkei in an in vitro epidermal model 132
Metabolic and mitochondrial remodelling in cisplatin resistance: studies on ovarian cancer cells and derived cytoplasmic hybrids 122
Overcome cisplatin -resistance by targetin glucose-6-phosphate dehydrogenase with the combination of liposomal cisplatin and 6-amino nicotinamide 115
Metabolic Profile of Cisplatin-resistant Phenotype - Studies in Ovarian Carcinoma Cell Lines 112
Metabolic profile of cisplatin-resistant phenotype: studies in ovarian carcinoma cell lines. 112
Rho0 cells and metabolomic approach to exploit mechanism of resistance to cisplatin in ovarian cancer cell lines. 110
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report 106
Anti-senescence activity of Salvia Haenkei on a skin cellular model 105
Potential effect of Salvia Haenkey on in vitro wound healing 99
Silybin, curcumin and quercetin as metabolic modulators in human resistant cancer cells 97
Silybin as a new tool to counteract doxorubicin resistance by targeting glucose uptake 96
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 95
Targeting glucose-6-phosphate dehydrogenase by 6-amino nicotinamide in combination with liposomal cisplatin as a strategy to sensitize ovarian resistant cancer cells 95
Insight into mitochondrial and metabolic asset of cisplatin resistant ovarian cancer cells. 93
Natural compounds as metabolic modulators in resistant cancer cells models 91
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 90
Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses CisplatinResistance: new pharmacological approach using Cisplatin liposome and 6-amino nicotinamide combination 90
Role of mitochondria in cisplatin-resistance phenomena 89
SILYBIN: A NATURAL COMPOUND ABLE TO OVERCOME DOXORUBICIN RESISTANCE PHENOMENA 85
Mitochondrial remodeling involved in cisplatin resistance 84
Effects of genistein on Leber’s hereditary optic neuropathy (LHON) mitochondrial metabolism. 83
Mitochondrial alterations involved in cisplatin resistance phenomena 83
Lipid-metabolic reprogramming in ovarian carcinoma cell lines resistant to cisplatin 82
Imbalance of mitochondrial "shaping proteins" and cisplatin resistance 81
Quercetin and Cisplatin combined treatment alter cell cycle and sensitize resistant cancer cell lines 81
Molecular mechanism of resistance to cisplatin: study of metabolism in ovarian cancer cells. 80
Cannabis Sativa modulates epithelial permeability in an in vitro intestinal inflammation model 80
Mitochondria as cisplatin targets: new apporach to counteract resistance mechanism 77
Natural polyphenol sensitize cancer cells to cisplatin effect on cell cycle 74
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 73
Silybin chemosensitize doxorubicin-resistant cells by targeting GLUT1 73
Natural compounds as metabolic modulators in resistant cancer models 73
Oxidative stress and metabolic reprogramming: study of pharmacological targets in cellular models of mithocondrial disease. 72
Targeting glucose-6-phosphate dehydrogenase with a combination of liposomal cisplatin and 6-amino nicotinamide as new strategy to overcome cisplatin-resistance 72
Calu-3 cells as in vitro model of bronchial epithelium for pharmacological studies of natural compounds 69
Cannabis Sativa L. modulates epithelial permeability in an in vitro intestinal inflammation model 68
Antioxidant and anti-inflammatory activities of Cannabis Sativa in epithelial intestinal cell 66
Natural compounds as metabolic modulators in resistant cancer cell models 64
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 62
Mitochondria on Cisplatin resistance: studies on ovarian cancer cells. 61
Natural polyphenols as chemosensitizer: studies in resistant cancer cells. 55
Mithocondria defect and cisplatin resistance: relationships on ovarian cancer cells. 53
Natural polyphenols chemosensitize cisplatin-resistant cells through cell cycle modulation 51
Silybin glycolysis inhibitor as promising agent in chemotherapy 47
Totale 6.456
Categoria #
all - tutte 20.761
article - articoli 10.640
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.401


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021346 0 0 0 0 29 8 48 30 46 81 80 24
2021/2022567 15 121 38 16 28 61 21 36 42 10 25 154
2022/2023521 105 34 4 38 125 68 5 34 73 2 22 11
2023/2024388 21 48 43 32 37 62 21 40 3 6 37 38
2024/20251.335 9 64 64 62 210 25 90 138 79 54 208 332
2025/20262.107 294 393 534 786 100 0 0 0 0 0 0 0
Totale 6.456